胸腔镜肺癌根治术治疗早期非小细胞肺癌的临床效果

目的分析胸腔镜肺癌根治术治疗早期非小细胞肺癌的临床效果。方法回顾性分析152例早期非小细胞肺癌患者的临床资料,将74例患者作为对照组,予以开胸肺癌根治术,将78例患者作为研究组,予以胸腔镜肺癌根治术。对比2组术后1年、2年、3年生存率和围术期情况、肺功能指标用力肺活量(FVC)、第1秒用力呼吸容积(FEV₁)、每分钟最大通气量(MVV)]、并发症发生率及术前、术后3 d视觉疼痛模拟评分(VAS)变化。结果研究组胸腔引流量、出血量较对照组少,住院时间较对照组短(P<0.05)。研究组FVC、FEV1、MVV水平较对照组高(P<0.05)。术后3 d,研究组VAS评分较对照组低(P<0.05)。研究组并发症发生率为5.13%(4/78),较对照组15.38%(12/74)低(P<0.05)。研究组术后1年生存率为98.68%(73/76)、2年生存率为86.84%(64/76)、3年生存率为81.58%(60/76),与对照组的97.26%(71/73)、87.57%(64/73)、79.45%(58/73)对比,无显著差异(P>0.0...

Clinical Therapeutic Effect of the Thoracoscopic Radical Resection for Early Non-small Cell Lung Cancer

Objective To analyze the clinical treatment effect of thoracoscopic radical resection for early non-small cell lung cancer.Methods Clinical data of 152 patients with early non-small cell lung cancer were retrospectively analyzed,74 patients treated with open resection of lung cancer were the control group,and 78 patients treated with thoracoscopic radical resection were the study group.1-,2-and 3-year survival rates and perioperative outcomes,pulmonary function indicators(FVC),1 second forced respiratory volume(FEV1),maximum ventilation per minute(MVV)),complication rate and changes in preoperative and postoperative 3d visual pain simulation score(VAS)were compared.Results The thoracic flow and bleeding in the study group were less than those of the control group,The hospitalization time in the study group was shorter than that of the control group(P<0.05);The FVC,FEV1,MVV level in the study group was higher than the control group(P<0.05);Postoperative 3d,the VAS score in the study group was lower than the control group(P<0.05);The incidence of complications in the study group was 5.13%(4/78)which was lower than 15.38%(12/74)in the control group(P<0.05);The 1-,2-and 3-year survival rates in the study group were 98.68%(73/76),86.84%(64/76),81.58%(60/76),and in the control group were 97.26%(71/73),87.57%(64/73),79.45%(58/73)(P>0.05).Conclusion Thoracoscopic radical resection for early non-small cell lung cancer is effective,and can reduce chest flow and bleeding,shorten hospital time,improve lung function,reduce pain,reduce incidence of complications and improve prognosis.